Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 17Colorectal Neoplasms 14Neoplasms 13Carcinoma, Hepatocellular 11Prostatic Neoplasms 7Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Stomach Neoplasms 5Anastomotic Leak 5Uterine Cervical Neoplasms 4Rectal Neoplasms 4Ovarian Neoplasms 4Multiple Myeloma 4Lymphoma, Follicular 4Disease 4Stomatitis 3Recurrence 3Pancreatic Neoplasms 3Myeloproliferative Disorders 3Lymphoma 3HIV Infections 3Depression 3Colonic Neoplasms 3Carcinoma, Renal Cell 3Vulvar Neoplasms 2Surgical Wound Infection 2Sleep Initiation and Maintenance Disorders 2Skin Neoplasms 2Sarcoma 2Postoperative Complications 2

Interventions

ledipasvir, sofosbuvir drug combination 1ledipasvir 1daclatasvir 1Sofosbuvir 1Simeprevir 1Ribavirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Hepatitis C, Chronic × 90 days × Clear all
NCT02771405 2026-04-13

FRI-STC

National Hepatology & Tropical Medicine Research Institute

Phase 3 Completed
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡